The major oncogenic driver of acute promyelocytic leukemia (APL) is the fusion protein PML-RAR originated from the chromosomal translocation t(15;17). target both ATRA- sensitive and resistant APL cells through their distinct acting mechanism, and are potential drug leads for APL treatment.
Tag: AEB071
Background The goal of this work is to report our experience
Background The goal of this work is to report our experience using loteprednol 0. measures were incidence of corneal haze and increased intraocular pressure. Results There were no statistically significant differences in preoperative characteristics between the two groups when comparing age sex best-corrected visual acuity spherical equivalent or keratometry. Both groups achieved excellent visual outcomes… Continue reading Background The goal of this work is to report our experience